Investment

Recent Earnings - May 05, 2026

Distilla AI

— 13 min read
Share

Editor's Notes:

  • One interesting idea from the recent earnings is the (mis)pricing of big pharma patent cliffs right now. Take Bristol-Myers Squibb as an example. The market is so terrified of its impending 2028 exclusivity cliff for blockbusters like Opdivo and Eliquis that it has punished the stock down to a ~9x forward P/E. But underneath the hood, BMS is quietly using AI and lab automation to identify lead molecules 50% faster, and its newer "Growth Portfolio" is already posting double-digit revenue gains to offset those legacy declines. With the street pricing this transition like a worst-case scenario, is it time for investors to take a serious look at this single-digit multiple?

I. Sector & Macro Thematic Takeaways

This section consolidates key trends, evaluating their novelty and potential market impact.

1. The AI-Driven Infrastructure Supercycle: Not Just Software, But Concrete & Power

Takeaway: While AI's software applications are widely discussed, the market is underestimating the physical infrastructure demands it is unleashing. This is creating an unprecedented, multi-year supercycle in data center construction, high-voltage power transmission, specialized cooling solutions, and enabling semiconductor components. This demand is structural, far exceeding traditional cyclical patterns, and is creating massive tailwinds for industrial, utility, and technology hardware providers.

Evidence Across Companies:

  • SPX Technologies reported 50-70% growth rates from the data center market in its HVAC segment, noting customers are looking to accelerate, and is undertaking significant capacity expansions (SPX Technologies).
  • WESCO International saw its data center sales surge 70% year-over-year to $1.4 billion, now representing 24% of total sales and its largest end market. WESCO declared the U.S. is at the beginning of an "industrial super cycle driven by AI-driven infrastructure investments, increased power generation, and reshoring" (WESCO International).
  • Trane Technologies reported an "exceptional demand" and "approximately 40% growth" in Americas Commercial HVAC bookings, with Applied Solutions bookings up over "160%" largely driven by data centers. Its acquisition of Stellar Energy, focused on modular data center cooling, is expected to grow to "$1 billion in 2-3 years" (Trane Technologies).
  • Hubbell Incorporated reported 40% growth in its data center markets in Q1 2026 and raised its full-year outlook to "over 25%," identifying high-voltage transmission (765 kV) as a significant incremental long-term growth opportunity (Hubbell Incorporated).
  • DTE Energy and Xcel Energy highlighted massive data center contracts (DTE: 1.4GW Oracle, 1GW Google, plus 2GW in discussions; Xcel: 20GW backlog, contracting 6GW by end-2027) necessitating billions in incremental generation and storage investment (DTE Energy Company, Xcel Energy Inc.).
  • Monolithic Power Systems (MPS) raised its Enterprise Data growth outlook to an "85% year-over-year floor" due to AI and CPU solutions, focusing on power density advancements (Monolithic Power Systems).
  • Tokyo Electron (TEL) projects the Calendar 2026 WFE (Wafer Fabrication Equipment) market to grow >15%, "potentially exceeding 20% growth due to strong inquiries" from AI, HBM, and leading-edge semiconductors (Tokyo Electron Limited). NGK Insulators corroborated this with its Digital Society Business profit soaring 63.5% from AI semiconductor demand (NGK Insulators, Ltd.).
  • Fabrinet saw DCI (Data Center Interconnect) revenue up 90% YoY, benefiting from deep hyperscaler engagement and investing in Co-Packaged Optics (CPO) for next-gen data centers (Fabrinet).
  • Atlassian is seeing its AI-powered Rovo platform drive ARR growth at twice the rate of non-Rovo users, and AI code generation tools boosting Jira tasks and user expansion, highlighting AI's role in enterprise productivity (Atlassian Corporation).

2. Supply Chain Regionalization & Vertical Integration: De-risking & Efficiency Redefined

Takeaway: Global geopolitical tensions and lessons from past disruptions are accelerating a strategic shift from pure "just-in-time" to "just-in-case" and "just-in-region." Companies are investing heavily in local manufacturing, vertical integration of critical components, and technology to make supply chains more resilient, agile, and less dependent on single points of failure, often as a direct response to tariffs or geopolitical risk. This is redefining operational efficiency and competitive advantage.

Evidence Across Companies:

  • Quanta Services is investing $500-700 million to double power transformer manufacturing capacity and expand off-site manufacturing facilities, specifically to address "36-month lead times for transformers" and act as a "labor force multiplier" (Quanta Services).
  • JBT Marel is establishing a new production center in Pune, India, for "optionality as tariffs evolve" and pursuing "supply chain regionalization efforts" including moving parts suppliers to the U.S. (JBT Marel Corporation).
  • Bio-Rad Laboratories initiated manufacturing of select life science instruments in China for the local market, aiming to "improve responsiveness and reduce tariff exposure" (Bio-Rad Laboratories).
  • Monolithic Power Systems (MPS) is actively managing and diversifying its supply chain "both inside and outside China" to avoid constraints and maintain agility (Monolithic Power Systems).
  • Xcel Energy has forged "partnerships with critical suppliers, tier-one EPC firms" and "alliances with GE Vernova and NextEra" to "address supply chain constraints and ensure project delivery" for its massive capital projects (Xcel Energy Inc.).

3. Bifurcated Consumer Demand: "K-Shape" Spending and the "Repair Not Replace" Economy

Takeaway: The consumer landscape is increasingly segmented. Affluent consumers continue to drive demand for luxury goods and high-end experiences, while value-conscious segments are seeing growth for essentials. The middle is under pressure, leading to "thoughtful choices," a preference for "value over volume," and a structural trend towards maintaining existing assets (e.g., cars) rather than purchasing new ones.

Evidence Across Companies:

  • Prada's Miu Miu brand remains a standout, growing 35% in FY2025, with Prada also improving, demonstrating resilience in luxury, especially in Asia Pacific and Americas. However, Europe and Japan are decelerating due to reduced tourist spending, and the Middle East is down 22% due to geopolitics (Prada S.p.A.).
  • Royal Caribbean Cruises reported a "record WAVE season" driven by consumers' "continued preference for experiences over purchasing goods." Strong demand for its premium ships and proprietary destinations ensures positive Caribbean yields despite elevated capacity (Royal Caribbean Cruises Ltd.).
  • O'Reilly Automotive reported an 8.1% increase in comparable store sales, driven by both professional and DIY customers, benefiting from consumers extending the lifespan of their vehicles due to economic pressures ("repair not replace") (O'Reilly Automotive, Inc.).
  • Colgate-Palmolive observed a "K-Shape World" strategy, where its super-premium Hill's Pet Nutrition segment is thriving, but North America volume/mix lags overall (Colgate-Palmolive).
  • Church & Dwight noted a "pressed consumer" environment, leading to increased growth in the value segment of laundry (ARM & HAMMER), and explicitly stated no price increases are planned to offset inflation (Church & Dwight Co., Inc.).
  • Floor & Decor Holdings experienced sales declines due to "weak demand environment" for big-ticket discretionary purchases, citing elevated mortgage rates, gas prices, and low consumer sentiment (Floor & Decor Holdings, Inc.).

4. Energy Transition & Security as a Dual Mandate: Nuclear's Comeback & Offshore Necessity

Takeaway: Geopolitical instability has shifted the energy narrative beyond pure decarbonization to a dual mandate of energy transition and security. This is driving investments in stable, dispatchable, low-carbon sources like nuclear, alongside renewables and a renewed, necessary focus on secure offshore oil and gas supplies. Rapid cost reductions in battery storage are also making it a viable solution.

Evidence Across Companies:

  • Brookfield Renewable is partnering with the U.S. government to accelerate new Westinghouse large-scale nuclear reactors, highlighting the importance of energy security. It also notes battery and energy storage as its fastest-growing technology, with capex costs decreasing 65-70% in 24 months (Brookfield Renewable Corporation).
  • Valaris Limited sees the long-term outlook for offshore drilling as "increasingly constructive," driven by "robust deepwater demand" and a growing consensus for a "structurally tighter oil supply later in the decade due to historic underinvestment" (Valaris Limited).
  • Mitsubishi Corporation is making its largest investment ever in the U.S. shale gas business and acquiring upstream gas assets in Brunei, reflecting a long-term commitment to traditional energy resources and security (Mitsubishi Corporation).
  • The Kansai Electric Power Company promotes "Energy 3.0" by integrating energy and solutions, leveraging nuclear power and developing renewables for decarbonization and energy stability (The Kansai Electric Power Company, Incorporated).

5. Pharmaceutical R&D Transformation: AI & M&A for Pipeline Renewal

Takeaway: The biopharmaceutical industry is undergoing a significant R&D transformation, driven by the imperative to renew pipelines in the face of patent expirations (Loss of Exclusivity, LOE). AI, data science, and strategic M&A are becoming critical tools to accelerate drug discovery, improve clinical trial efficiency, and expand therapeutic portfolios.

Evidence Across Companies:

  • Amgen is embedding AI and data science across R&D, manufacturing, and regulatory processes, accelerating antibody lead optimization by 50% and improving clinical trial enrollment threefold. It faces 32% LOE impacts on key products but is investing in new assets like Meritide (obesity) and Olpasiran (Lp(a)) (Amgen Inc.).
  • Bristol-Myers Squibb (BMS) is driving "top-tier R&D productivity" by investing in "AI tools and laboratory automation" to "identify lead molecules 50% faster and reduce cycle times by 30% in late development." Business development "remains a priority" for expanding its early to mid-stage pipeline (Bristol-Myers Squibb Company).
  • Moderna is leveraging AI and robotics to accelerate drug discovery, advancing a diversified product pipeline across flu, combo vaccines, oncology, and rare diseases, moving beyond its COVID-19 origins (Moderna, Inc.).
  • BioMarin Pharmaceutical expanded its portfolio significantly through the Amicus acquisition, accelerating 2026 revenue growth and leveraging its scale to drive diagnosis and treatment rates for new rare disease markets (BioMarin Pharmaceutical Inc.).

6. Japanese Corporates: Capital Allocation & Diversification for Shareholder Value

Takeaway: Major Japanese corporations, often criticized for conservative capital allocation, are actively engaging in strategies to enhance shareholder value. This includes significant share buybacks, progressive dividend policies, and strategic diversification into more stable, non-core businesses (e.g., real estate, finance) to offset cyclicality in core operations.

Evidence Across Companies:

  • Mitsubishi Corporation continued its substantial share buyback program (794.3 billion JPY) and explicitly committed to "flexibly and proactively allocate additional capital to growth investments and shareholder returns" (Mitsubishi Corporation).
  • Marubeni Corporation has a commitment to robust shareholder returns through a progressive dividend policy and a targeted total return ratio of approximately 40%, including agile share repurchases (Marubeni Corporation).
  • Japan Airlines (JAL) is significantly investing in its "Mileage/Finance/Commerce Business," which delivered a 19.5% profit increase and targets further growth, reflecting diversification efforts (Japan Airlines Co., Ltd.).
  • Mitsui O.S.K. Lines (MOL) increased its dividend to JPY 200/share despite a profit decline, and is expanding investments in overseas real estate and its Wellbeing & Lifestyle business (Mitsui O.S.K. Lines, Ltd.).
  • The Kansai Electric Power Company saw its Life and Business Solutions business (real estate leasing) increase profit by 49.0% (The Kansai Electric Power Company, Incorporated).

7. China's Nuanced Economic Picture: Tech/Industrial Strength Amidst Consumer/Property Weakness

Takeaway: The Chinese economy presents a mixed and diverging picture. While consumer confidence and the property market remain weak, leading to declining sales for consumer-facing and property-dependent businesses, there is strong and sustained demand for high-tech industrial components, communications infrastructure, and automation, often driven by global AI trends or government initiatives.

Evidence Across Companies:

  • A. O. Smith Corporation reported China sales down 17% in local currency in Q1, expected to decline "low double digits" for the full year due to "discontinuation of government stimulus programs and low consumer confidence" (A. O. Smith Corporation).
  • Carrier Global described the residential market in China as "very challenging, with no real signs of improvement," making it "difficult to call a bottom" (Carrier Global Corporation).
  • Prada saw robust growth in Asia Pacific (especially Mainland China, Hong Kong, Macau, Korea) for luxury goods, but Tokyo Electron noted its sales proportion in China dropped to 31.8% and expects the WFE market in China to "remain flat in the future, particularly in the commodity area" due to regulations and investment shifts (Tokyo Electron Limited).
  • MISUMI Group highlighted "robust performance overall, driven by the capture of demand related to communications in China and other areas" for its FA Business, and "robust growth in China and Asia" for its Die Components Business (MISUMI Group Inc.).

II. Debates & Uncertainties

AI-Driven Infrastructure Boom: Durable Supercycle or Cyclical Peak?

Evidence:

  • SPX Technologies: "data center market shows strong and accelerating demand... growth rates for data centers increasing from 50% to 70% this year" (SPX Technologies).
  • WESCO International: "70% YoY surge in data center sales... declared the beginning of an industrial super cycle driven by AI-driven infrastructure investments" (WESCO International).
  • Trane Technologies: "Global data center orders were up over 500% in Q1 2026. The current data center backlog fully covers the expected $1.5 billion in data center sales for the year" (Trane Technologies plc).
  • Hubbell Incorporated: "Data center markets grew approximately 40% [in Q1], supported by strong order activity and continued buildout by hyperscaler and colocation customers. The company has enhanced visibility to increase its full-year outlook for data center markets to over 25%" (Hubbell Incorporated).
  • Quanta Services: Projects 70-110% revenue growth for Technology and Load Centers, driven by "AI build and cloud-based products" and utility "firming up large load requests" (Quanta Services).
  • Monolithic Power Systems: Raised Enterprise Data growth outlook to an "85% year-over-year floor" (Monolithic Power Systems).

Bull view: The AI revolution is in its early stages, necessitating a multi-year, foundational build-out of infrastructure. Hyperscalers' massive, long-term capital commitments, combined with the increasing power density and specialized cooling required, signal a sustained supercycle. Companies like those above are comprehensive providers across the entire data center ecosystem, ensuring continued market leadership and capture of this secular trend for decades.

Bear view: While current demand is undeniable, the extraordinary pace of growth might be a front-loaded, speculative surge that could normalize or even lead to overcapacity once initial build-outs complete. Competition could intensify as more players enter, or technological shifts (e.g., more efficient AI chips, edge computing) might eventually temper the intensity of large-scale data center construction. An over-reliance on this single, albeit massive, growth driver could be a risk if the AI CapEx cycle moderates unexpectedly, leading to a "digestion phase."

Why it matters: This debate directly influences the long-term revenue and profitability projections for a vast array of companies, from component suppliers to utilities and construction services. A sustained supercycle supports continued premium valuations, whereas a significant slowdown could necessitate new growth strategies and impact investor confidence.

Consumer Resilience vs. Inflationary Exhaustion & GLP-1 Impact

Evidence:

  • Church & Dwight: Explicitly stated, "The consumer is currently pressed, and pushing price increases in this environment is not advisable," opting to rely on productivity to offset $25-30 million in incremental inflation (Church & Dwight Co., Inc.).
  • O'Reilly Automotive: Reported strong Q1 comparable sales (8.1%) but management remains "cautious about sustained inflation pressure and potential future shocks" despite no current demand impact from rising fuel costs (O'Reilly Automotive, Inc.).
  • The Hershey Company: Observed "mild" but consistent GLP-1 impacts and an "increasing SNAP headwind," alongside "thoughtful choices" from consumers, despite strong Easter performance (The Hershey Company).
  • Floor & Decor Holdings: Attributed sales decline to "elevated mortgage rates, higher gas prices, geopolitical tensions, and low consumer sentiment" impacting "big-ticket discretionary purchases" (Floor & Decor Holdings, Inc.).
  • Colgate-Palmolive: Noted a "K-Shape World" strategy, with super-premium Hill's Pet Nutrition thriving while North America lags (Colgate-Palmolive Company).

Bull view: Consumers, particularly in resilient categories like essential auto parts (O'Reilly), affordable indulgences (Hershey), or premium/value segments (Colgate, Church & Dwight), remain adaptive. Companies with strong brands, effective value propositions, and agile pricing/cost management can navigate inflation without losing significant demand. GLP-1 impacts are mild and manageable, with companies adapting product portfolios.

Bear view: Persistent inflation and higher interest rates are eroding purchasing power for a significant portion of consumers, leading to "exhaustion." This is evident in lagging volume performance in some categories and a shift to lower-priced goods (Floor & Decor). The GLP-1 impact, while currently mild, could become a structural headwind for the food and beverage industry long-term, fundamentally altering consumer habits. If economic conditions worsen, even essential or affordable discretionary spending could be curtailed.

Why it matters: This debate dictates the effectiveness of pricing strategies, product portfolio resilience, and the overall demand environment for consumer-facing companies. The ability to pass on costs without sacrificing volume or to adapt to changing consumer preferences is crucial for maintaining profitability and funding growth initiatives.

Evidence:

  • NCLH: Explicitly cited "Recent events related to the conflict in the Middle East have impacted bookings across all three brands, especially in Europe during the summer season," leading to "softer demand related to heightened geopolitical uncertainty" (Norwegian Cruise Line Holdings Ltd.).
  • Estée Lauder: Noted the Middle East conflict "negatively impacted third-quarter sales growth in EUKEM by approximately 1 percentage point," with further impacts expected (The Estée Lauder Companies Inc.).
  • Trane Technologies: Anticipates Middle East geopolitical events will result in approximately $50 million in lost revenues and an estimated $0.05 EPS impact in Q2 (Trane Technologies plc).
  • Bio-Rad Laboratories: Experienced a direct $11 million revenue impact in Q1 2026 from the Middle East conflict in its Clinical Diagnostics segment, leading to revised negative guidance for the full year (Bio-Rad Laboratories).
  • Prada: Reported a stark "down 22.2%" in retail net sales in the Middle East for Q1 2026 due to the conflict (Prada S.p.A.).
  • Merit Medical Systems: Cited Middle East shipping challenges leading to ~$1.5 million in undelivered orders (Merit Medical Systems, Inc.).
  • Allison Transmission and Lincoln Electric also noted direct or undetermined impacts on sales (Allison Transmission Holdings, Inc., Lincoln Electric Holdings, Inc.).

Bull view: Geopolitical impacts are often localized and temporary. Companies with diversified geographic exposure can reallocate resources, leverage strong brands in unaffected markets (e.g., Prada in APAC/Americas), and use hedging (Royal Caribbean's fuel hedging) to mitigate direct financial hits. The long-term underlying demand for quality products and experiences remains strong.

Bear view: Protracted geopolitical conflicts can have broader ripple effects, impacting global supply chains, energy prices, and overall consumer/industrial confidence far beyond the directly affected regions. The accumulation of these smaller, localized impacts can become a significant drag on consolidated profitability, making long-term strategic planning challenging and introducing unpredictable volatility across various sectors.

Why it matters: This macro debate fundamentally influences top-line growth, cost structures, and strategic market focus. Persistent negative impacts could lead to margin compression and downward revisions in earnings estimates, whereas successful adaptation or quick resolution could unlock pent-up demand.

Pharma Regulatory & Litigation Risks vs. Pipeline Strength

Evidence:

  • Amgen: Faces FDA proposal to withdraw Tavneos approval due to process concerns, and "ongoing tax court litigation" with the IRS, with a draft NOPA for 2016-2018 asserting "significant adjustments related to profit allocation" (Amgen Inc.).
  • Bristol-Myers Squibb: Opdivo revenue declined 8% due to a wholesaler inventory drawdown, and faces continuous generic erosion for older brands (Bristol-Myers Squibb Company).
  • BioMarin Pharmaceutical: Q1 EPS impacted by a $31 million charge for an unsuccessful process qualification campaign. Faces ongoing ITC hearing and patent enforcement efforts for Voxzogo (BioMarin Pharmaceutical Inc.).
  • Moderna: Reported a GAAP net loss of $1.3 billion, including an $878 million charge for a litigation settlement, with potential for an additional $1.3 billion payment (Moderna, Inc.).

Bull view: These are manageable risks. Amgen and BioMarin express confidence in defending their products/patents. The financial impacts from litigation (Moderna) are largely one-off or already accounted for. Pharma companies have robust legal teams and diversified pipelines designed to offset LOE and navigate regulatory hurdles. Positive clinical data from new pipeline assets (e.g., Amgen's Meritide, BioMarin's Voxzogo expansion) will drive future growth and derisk the business.

Bear view: Regulatory setbacks (Tavneos) and major litigation (Amgen, Moderna) can lead to significant, unforecasted financial liabilities and reputational damage. The constant pressure from generic erosion (BMS) means a continuous need for costly pipeline replenishment, which itself carries high clinical and regulatory risks. These factors can create persistent overhangs, dilute investor confidence, and strain financial resources needed for R&D and M&A.

Why it matters: These risks directly impact pharma companies' core business models, long-term revenue potential, and valuation. Successfully navigating these challenges is crucial for validating R&D investments and maintaining market leadership.

Disclaimer: This content is generated using AI, synthesizing public data (filings, reports, news) and social media (Reddit, X). It may contain errors, inaccuracies, or hallucinations. Nothing herein constitutes financial advice. This newsletter is for informational purposes only; please consult a qualified professional and conduct your own due diligence before making any investment decisions.

Read more